Dual Biologic Therapy With Dupilumab and Mepolizumab in Refractory Atopic Dermatitis and Severe Eosinophilic Asthma
Australasian Journal of Dermatology · 15.11.2026
DOI: 10.1111/ajd.70233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australasian Journal of Dermatology, online erschienen am 15.11.2026. Verfasst von Lachlan D W Lau und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Royal Melbourne Hospital, Parkville, Victoria, Australia. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
- Department of Immunology and Allergy, Royal Melbourne Hospital, Parkville, Victoria, Australia.
- Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.
- Department of Dermatology, Monash Health, Clayton, Victoria, Australia.
ORCID-Profile: Lachlan D W Lau, Anthony Moussa, Celestine C Wong
Zitieren
APA
Lau, L. D. W., Moussa, A., Patel, M., & Wong, C. C. (2026). Dual Biologic Therapy With Dupilumab and Mepolizumab in Refractory Atopic Dermatitis and Severe Eosinophilic Asthma. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.70233
Vancouver
Lau LDW, Moussa A, Patel M, Wong CC. Dual Biologic Therapy With Dupilumab and Mepolizumab in Refractory Atopic Dermatitis and Severe Eosinophilic Asthma. Australasian Journal of Dermatology. 2026. doi:10.1111/ajd.70233
BibTeX
@article{Lau2026,
author = {Lau, Lachlan D W and Moussa, Anthony and Patel, Mittal and Wong, Celestine C},
title = {Dual Biologic Therapy With Dupilumab and Mepolizumab in Refractory Atopic Dermatitis and Severe Eosinophilic Asthma},
journal = {Australasian Journal of Dermatology},
year = {2026},
doi = {10.1111/ajd.70233}
}
EUVIMED